ß-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma

被引:24
|
作者
Zhang, Yi [1 ,2 ,3 ]
Xu, Hongwei [4 ]
Cui, Guofei [2 ,3 ]
Liang, Binyong [5 ]
Chen, Xiangzheng [6 ,7 ]
Ko, Sungjin [8 ,9 ,10 ]
Affo, Silvia [11 ]
Song, Xinhua [12 ]
Liao, Yi [13 ]
Feng, Jianguo [14 ,15 ]
Wang, Pan [16 ]
Wang, Haichuan [2 ,3 ,6 ,7 ]
Xu, Meng [17 ]
Wang, Jingxiao [18 ]
Pes, Giovanni M. [19 ]
Ribback, Silvia [20 ]
Zeng, Yong [6 ,7 ]
Singhi, Aatur [8 ,9 ,10 ]
Schwabe, Robert F. [21 ]
Monga, Satdarshan P. [8 ,9 ,10 ]
Evert, Matthias [22 ]
Tang, Liling [1 ]
Calvisi, Diego F. [22 ]
Chen, Xin [2 ,3 ,23 ]
机构
[1] Chongqing Univ, Coll Bioengn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400044, Peoples R China
[2] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Liver Ctr, San Francisco, CA 94143 USA
[4] Sichuan Univ, Ctr Liver Transplantat, Dept Liver Surg, West China Hosp, Chengdu, Sichuan, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr,Dept Surg, Wuhan, Peoples R China
[6] Sichuan Univ, West China Hosp, Dept Liver Surg, Liver Transplantat Div, Chengdu, Peoples R China
[7] Sichuan Univ, West China Hosp, Lab Liver Surg, Chengdu, Peoples R China
[8] Univ Pittsburgh, Sch Med, Dept Pathol & Med, Pittsburgh, PA USA
[9] Univ Pittsburgh, Sch Med, Pittsburgh Liver Res Ctr, Pittsburgh, PA USA
[10] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[11] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain
[12] Capital Med Univ, Sch Tradit Chinese Med, Beijing, Peoples R China
[13] Shenzhen Univ, Cent Lab, Hlth Sci Ctr, Shenzhen Peoples Hosp 2,Affiliated Hosp 1, Shenzhen, Guangdong, Peoples R China
[14] Southwest Med Univ, Affiliated Hosp, Dept Anesthesiol, Luzhou, Peoples R China
[15] Southwest Med Univ, Lab Anesthesiol, Luzhou, Peoples R China
[16] Beijing Acad Agr & Forestry Sci, Beijing Vegetable Res Ctr, Collaborat Innovat Ctr Agr Prod Proc & Nutr & Hlt, Beijing, Peoples R China
[17] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Gen Surg, Xian, Peoples R China
[18] Beijing Univ Chinese Med, Sch Life Sci, Beijing, Peoples R China
[19] Univ Sassari, Dept Med Surg & Expt Sci, Sassari, Italy
[20] Univ Greifswald, Inst Pathol, Greifswald, Germany
[21] Columbia Univ, Dept Med, New York, NY USA
[22] Univ Regensburg, Inst Pathol, Franz Josef Str Allee 11, D-93053 Regensburg, Germany
[23] Univ Hawaii, Canc Biol Program, Canc Ctr, Honolulu, HI 96813 USA
基金
美国国家卫生研究院;
关键词
ss-Catenin; Hippo/YAP; Intrahepatic Cholangiocarcinoma; TEADs; BETA-CATENIN; TAZ; YAP; INHIBITOR; DISTINCT; COMPLEX; GROWTH;
D O I
10.1053/j.gastro.2022.04.028
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: YES-associated protein (YAP) aberrant activation is implicated in intrahepatic cholangiocarcinoma (iCCA). Transcriptional enhanced associate domain (TEAD)-mediated transcriptional regulation is the primary signaling event downstream of YAP. The role of Wnt/ss-Catenin signaling in cholangiocarcinogenesis remains undetermined. Here, we investigated the possible molecular interplay between YAP and ss-Catenin cascades in iCCA. METHODS: Activated AKT (Myr-Akt) was coexpressed with YAP (YapS127A) or Tead2VP16 via hydrodynamic tail vein injection into mouse livers. Tumor growth was monitored, and liver tissues were collected and analyzed using histopathologic and molecular analysis. YAP, ss-Catenin, and TEAD interaction in iCCAs was investigated through coimmunoprecipitation. Conditional Ctnnb1 knockout mice were used to determine ss-Catenin function in murine iCCA models. RNA sequencing was performed to analyze the genes regulated by YAP and/or ss-Catenin. Immunostaining of total and nonphosphorylated/ activated ss-Catenin staining was performed in mouse and human iCCAs. RESULTS: We discovered that TEAD factors are required for YAP-dependent iCCA development. However, transcriptional activation of TEADs did not fully recapitulate YAP's activities in promoting cholangiocarcinogenesis. Notably, b-Catenin physically interacted with YAP in human and mouse iCCA. Ctnnb1 ablation strongly suppressed human iCCA cell growth and Yap-dependent cholangiocarcinogenesis. Furthermore, RNA-sequencing analysis revealed that YAP/ transcriptional coactivator with PDZ-binding motif (TAZ) regulate a set of genes significantly overlapping with those controlled by ss-Catenin. Importantly, activated/nonphosphorylated ss-Catenin was detected in more than 80% of human iCCAs. CONCLUSION: YAP induces cholangiocarcinogenesis via TEAD-dependent transcriptional activation and interaction with ss-Catenin. ss-Catenin binds to YAP in iCCA and is required for YAP full transcriptional activity, revealing the functional crosstalk between YAP and ss-Catenin pathways in cholangiocarcinogenesis.
引用
收藏
页码:481 / 494
页数:14
相关论文
共 50 条
  • [1] B-CATENIN SUSTAINS AND IS REQUIRED FOR YAP ONCOGENIC ACTIVITY IN CHOLANGIOCARCINOMA
    Chen, Xin
    HEPATOLOGY, 2022, 76 : S1392 - S1393
  • [2] β-Catenin Is a Novel Target in YES-associated Protein-driven Cholangiocarcinoma
    Lozano, Anthony
    Lujambio, Amaia
    GASTROENTEROLOGY, 2022, 163 (02) : 374 - 376
  • [3] Angiotensin Receptor Blockade Attenuates Cholangiocarcinoma Cell Growth By Inhibiting the Oncogenic Activity of Yes-Associated Protein
    Tsuji, Yuki
    Kaji, Kosuke
    Saikawa, Soichiro
    Kitade, Mitsuteru
    Moriya, Kei
    Namisaki, Tadashi
    Akahane, Takemi
    Yoshiji, Hitoshi
    HEPATOLOGY, 2018, 68 : 1245A - 1245A
  • [4] Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein
    Tsuji, Yuki
    Kaji, Kosuke
    Saikawa, Soichiro
    Seki, Kenichiro
    Sato, Shinya
    Nakanishi, Keisuke
    Kawaratani, Hideto
    Kitade, Mitsuteru
    Moriya, Kei
    Namisaki, Tadashi
    Yoshiji, Hitoshi
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E380 - E380
  • [5] Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein
    Saikawa, Soichiro
    Kaji, Kosuke
    Nishimura, Norihisa
    Seki, Kenichiro
    Sato, Shinya
    Nakanishi, Keisuke
    Kitagawa, Koh
    Kawaratani, Hideto
    Kitade, Mitsuteru
    Moriya, Kei
    Namisaki, Tadashi
    Mitoro, Akira
    Yoshiji, Hitoshi
    CANCER LETTERS, 2018, 434 : 120 - 129
  • [6] Both TEAD-Binding and WW Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein
    Zhao, Bin
    Kim, Joungmok
    Ye, Xin
    Lai, Zhi-Chun
    Guan, Kun-Liang
    CANCER RESEARCH, 2009, 69 (03) : 1089 - 1098
  • [7] YES-ASSOCIATED PROTEIN 1 AND ITS ONCOGENIC FUNCTION IN MENINGIOMAS
    Baia, Gilson S.
    Caballero, Otavia L.
    Orr, Brent A.
    Lal, Anita
    Ho, Janelle S.
    Cowdrey, Cynthia
    Tihan, Tarik
    Mawrin, Christian
    Riggins, Gregory J.
    NEURO-ONCOLOGY, 2012, 14 : 12 - 12
  • [8] β-Catenin and Yes-Associated Protein 1 Cooperate in Hepatoblastoma Pathogenesis
    Min, Qian
    Molina, Laura
    Li, Jing
    Michael, Adeola O. Adebayo
    Russell, Jacquelyn O.
    Preziosi, Morgan E.
    Singh, Sucha
    Poddar, Minakshi
    Matz-Soja, Madlen
    Ranganathan, Sarangarajan
    Bell, Aaron W.
    Gebhardt, Rolf
    Gaunitz, Frank
    Yu, Jinming
    Tao, Junyan
    Monga, Satdarshan P.
    AMERICAN JOURNAL OF PATHOLOGY, 2019, 189 (05): : 1091 - 1104
  • [9] Yes-Associated Protein is required for proper embryogenesis in the mouse.
    Boone, B
    Morin-Kensicki, E
    Howell, M
    Stonebraker, J
    Magnuson, T
    O'Neal, W
    Milgram, S
    DEVELOPMENTAL BIOLOGY, 2003, 259 (02) : 496 - 496
  • [10] Yes-associated protein plays oncogenic roles in human sporadic colorectal adenomas
    Fan, Lei
    Guo, Xingyi
    Washington, Mary K.
    Shi, Jiajun
    Ness, Reid M.
    Liu, Qi
    Wen, Wanqing
    Huang, Shuya
    Liu, Xiao
    Cai, Qiuyin
    Zheng, Wei
    Coffey, Robert J.
    Shrubsole, Martha J.
    Su, Timothy
    CARCINOGENESIS, 2025, 46 (01)